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The p21
MDA6 gene product induces cell cycle arrest in p53-null pendent induction of p21 MDA6 has been observed in response human leukemic cells exposed to differentiation stimuli. We to both differentiating and DNA damaging agents. these p53-positive cell lines in a p21 MDA6 -independent mancomplex formation. They also provide functional evidence that ner. 16 Thus, it is apparent that p21 MDA6 expression is not p21 MDA6 induction does not appear to be required for Ara-Cnecessary for apoptosis to proceed in all cell types, but its induced apoptosis, G 1 arrest, or the resulting reduction in the induction may be required in certain circumstances self-renewal capacity of HL-60 cells. Keywords: p21; MDA-6; apoptosis; Ara-C; cell cycle arrest; HLdepending on the cell line and the provoking stimulus.
cells
There are also unresolved questions regarding the role of p21 MDA6 in apoptosis induced by antineoplastic agents in human myeloid leukemia cells. For example, studies demonIntroduction strating the failure of 1-␤-D-arabinofuranosylcytosine (Ara-C) to induce p21 MDA6 in HL-60 cells, imply, albeit indirectly, the Human p21 melanoma differentiation-associated gene 6 absence of a role for p21 MDA6 in drug-induced apoptosis. 11 On (MDA6), 1-4 also referred to as wild-type p53 activated factor-1 the other hand, Dou and Lui 26 described dephosphorylation of (WAF1), 5 cyclin-dependent kinase (CDK) interacting protein-1 the retinoblastoma protein (pRb) in HL-60 cells exposed to (CIP1), 6 ,7 and senescent cell-derived inhibitor-1 (SDI1) 8 is an similar concentrations of Ara-C. Since pRb dephosphorylation inhibitor of several CDKs. p21 MDA6 appears to be a normal and G 1 arrest are known to be downstream consequences of constituent of active cyclin/CDK complexes in cells expressing p21 MDA6 induction, the latter observation is potentially comfunctional p53.
9,10 The p53-dependent induction of p21
MDA6
patible with a role for p21 MDA6 in drug-induced cell death. has been well characterized in response to DNA damage and Currently, little direct evidence exists linking p21 MDA6 differentiating agents. 11, 12 As the molar ratio of p21 MDA6 to expression and cell death in human leukemia cells. The aim CDK increases above 1, the kinase activity of a number of of this study was to gain further insight into the functional cyclin/CDK combinations is inhibited, 13,14 resulting in G 1 or role of p21 MDA6 with regard to both differentiation and drug-G 2 cell cycle arrest.
12,15 A certain percentage of these cells induced apoptosis in a human myeloid leukemia cell line (HLsubsequently undergoes apoptosis. More recently, p53-inde-60) known to be p53 null due to a major deletion in the p53 gene. 27 To this end, an HL-60 cell line stably transfected with and expressing antisense p21 MDA6 was employed to characterize the effects of p21 MDA6 dysregulation on responses to 
Materials and methods

Drugs and reagents
Phorbol 12-myristate 13-acetate (Sigma Chemical, St Louis, MO, USA) was diluted in sterile DMSO. 1-␤-D-arabinofuranosylcytosine (free base; Sigma) was diluted in sterile water. PMA was stored at −20°C under light-free conditions and diluted to appropriate final concentrations in media. Ara-C was stored at 4°C and diluted to appropriate final concentrations in media. Vehicle controls of water and DMSO (р0.01%) were included in all experiments and consistently found to be equivalent to drug-free controls in gene expression, protein expression, and occurrence of apoptosis.
Cell culture and drug exposure
The human promyelocytic leukemia cell line, HL-60, was derived from a cell line originally described by Gallegher et al. 28 U937 monocytic leukemia cells were derived from a cell line as previously reported. 29 HL-60 cell lines expressing anti- 
Southern analysis
ment. All cells were grown in RPMI 1640 (phenol red-free formulation; Sigma) supplemented with 0.2% sodium bicarbonTotal cellular DNA from 1 × 10 7 cells was isolated following a method described in Current Protocols in Molecular ate, 1.0% sodium pyruvate, non-essential amino acids, Lglutamine, PSN antibiotic mix (Sigma) and 10% heat-inactiBiology. 66 DNA was quantitated and 10 g was digested to completion with BamHI at 37°C for 4 h. The DNA was separvated fetal bovine serum (Hyclone, Logan, UT, USA); empty vector and pREP4-p21 MDA6 cells were also supplemented with ated on a 0.7% agarose/1 × TBE (45 mM Tris-borate, 10 mM EDTA, pH 8.0) gel at 100 V for 6 h. The DNA was blotted onto 400 g/ml hygromycin B. All cultures were maintained under a fully humidified atmosphere of 95% air and 5% CO 2 at nylon (Schleicher and Schuell, Keene, MD, USA) by upward capillary transfer for 16 h with 0.5 M NaOH/1.5 M NaCl and 37°C. Cultures were routinely screened for mycoplasma contamination with a rapid hybridization assay for mycoplasma then cross-linked to nylon by baking at 80°C for 2 h. Blots were then hybridized with a HincII fragment of the expression RNA (Gen-Probe, San Diego, CA, USA) and consistently found to be mycoplasma-free. Cell densities were determined vector containing the hygromycin B resistance gene. The probe was nick-translated with ␣-dCTP 32 (3000 Ci/mM) (New by Coulter (Hialeah, FL, USA) counter and cell viability was assessed by hematocytometer and trypan blue exclusion. For
England Nuclear, Boston, MA, USA) using a kit and protocol from Life Technologies (Gaithersburg, MD, USA). Blots were experimental incubations, cells in log-phase growth were sus- (1 × SSC = 150 mM NaCl, 15 mM sodium citrate) at 65°C and placed on Fuji RX film (Fuji Photo Film, Tokyo, Japan) with Quantitative spectrofluorophotometry of apoptotic DNA fragintensifying screens and exposed at −90°C.
ments was performed as previously described. 31 Briefly, cell pellets (3 × 10 6 ) were lysed overnight at 4°C in 300 l of 0.1% Triton X-100, 5 mM Tris-HCl (pH 8.0), and 20 mM EDTA. The lysates were centrifuged at 48 000 g for 40 min at 4°C and the Western analysis pellets discarded. The presence of low molecular weight DNA fragments in all lysates was determined by diluting 20 l samples in 980 l assay buffer (3 M NaCl, 10 mM Tris-HCl, Whole cell pellets (1 × 10 7 ) were washed twice in PBS. Cell 1 mM EDTA, 1 g/ml bisbenzimide trihydrochloride) and pellets were then resuspended in 50 l PBS and lysed by the monitoring net fluorescence (ex = 365, em = 460). DNA addition of 50 l 2 × loading buffer (1× = 30 mM Tris-base, values were calculated against a calf thymus DNA standard pH 6.8, 2% SDS, 2.88 mM ␤-mercaptoethanol, 10% glycerol, and expressed as ng DNA/10 6 cells. 0.1% bromophenol blue). Lysates were boiled for 10 min, centrifuged at 12 800 g for 5 min, and quantified using Coomassie protein assay reagent (Pierce, Rockford, IL, USA).
Cell morphology
Equal amounts of protein (25 g) were separated by SDS-PAGE (5% stacker and 6% (pRb) or 12% (p21 MDA6 and Following treatment, cytocentrifuge slides were prepared conp27 kip1 ) and electroblotted to nitrocellulose. The blots were taining 8 × 10 4 cells per slide. Slides were stained with 20% stained in 0.1% amido black and destained in 5% acetic acid Wright-Giemsa and photomicrographs taken at 500× showing to ensure transfer and equal loading. The blots were then typical cell morphology using a Polaroid Microcam and 331 blocked in TBS-Tween (0.05%) and 5% milk for 1 h at 22°C. film (Polaroid, Atlanta, GA, USA). The percentage of apoptotic Blots were incubated in fresh blocking solution and probed cells was determined by evaluating approximately 500 cells for 4 h with the appropriate dilution of primary antibody: pRb per condition in triplicate. (1:500 (G3-245); Pharmingen, San Diego, CA, USA); p21 MDA6 and p27 kip1 (both 1:500; Transduction Laboratories, Lexington, KY, USA). Blots were washed 3 × 5 min in TBS-T and Cell cycle analysis then incubated with a 1:1000 dilution of peroxidase-conjugated secondary antibody (Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA) in TBS-T for 1 h at 22°C. Blots were Following drug treatment, cells were pelleted at 500 g and resuspended in 1 ml cell cycle buffer (0.38 mM sodium citrate, again washed 3 × 5 min in TBS-T and then developed by enhanced chemiluminesence (Pierce). Autoradiographs were 0.1% Triton X-100, 7 Kunitz/ml RNase B, 50 g/ml propidium iodide) at a concentration of 1 × 10 6 cells/ml. Samples were quantitated via laser densitometry (Molecular Dynamics, Sunnyvale, CA, USA).
placed on ice overnight and analyzed using a Becton-Dickin- 
H1 kinase assay
Results
Following treatment, cells were washed twice with PBS and HL-60 cells were transfected by electroporation with either resuspended in homogenization buffer (30 mM ␤-glycerothe pREP4 vector or the pREP4 vector containing the p21 MDA6 phosphate, 5 mM NaF, 20 mM MgCl 2 , 2.5 mM EGTA, 30 mM coding region in the antisense orientation. Transfected cells HEPES pH 7.4, and 10 g/ml each chymostatin, leupeptin, were selected for resistance to hygromycin by limiting dilution aprotinin, pepstatin and soybean trypsin inhibitor (CLAPS).
and analyzed by Southern blot for the presence of the hygroThe cell suspension was dounce homogenized, briefly sonmycin resistance gene (Figure 1 ). HL-60 cells do not express icated, and centrifuged at 12 800 g for 15 min at 4°C. The detectable levels of p21 MDA6 constitutively, but express supernatant was transferred to a new tube and the protein p21 MDA6 in response to certain agents or conditions that concentration quantified using Coomassie protein assay induce differentiation (ie PMA). Stably transfected cells were reagent (Pierce) observed at 12 h and was expressed at Ϸ15% of levels DuPont, Wilmington, DE, USA) and incubating at 32°C for 15 observed in HL-60/V2 cells at 24 h (Figure 2a ). Because min. Kinase reactions were performed in triplicate with and p21 MDA6 binds to and inhibits the kinases that help maintain without substrate. The reactions were terminated by spotting pRb in a hyperphosphorylated state, 29 we next examined the 20 l on to phosphocellulose disks and washing twice for 5 phosphorylation status of pRb. Interestingly, although the levmin with 1% H 3 PO 4 and twice with H 2 O. Incorporated phosels of p21 MDA6 were greatly attenuated in the HL-60/AS5 cells phate was determined by scintillation counting.
in response to PMA, these cells exhibited dephosphorylation of pRb similar to treated control cells (Figure 2b) . One of the possible consequences of pRb dephosphorylation is binding to the E2F transcription factor, an event impli-E2F electrophoretic mobility shift assay (EMSA) cated in regulating the G 1 -S transition. [34] [35] [36] [37] Moreover, it has recently been reported that interactions between E2F and the pRb-like protein p130 can be affected by p21 MDA6 . 38 Hence, An EcoRI-HindII fragment of the adenovirus E2 promoter containing two E2F binding sites (TTTCGCGC) was end-labeled attempts were made to evaluate the status of E2F-containing complexes in cells expressing antisense p21 MDA6 using an using Klenow fragment and used as the probe for the gel-retardation assay. 32, 33 Eight micrograms of whole cell extracts from electrophoretic mobility shift assay 33, 39, 40 (Figure 3 ). An E2F-pRb complex could be clearly seen in extracts of unstimulated HL-60 cells were incubated in 13 l protein binding buffer for 15 min on ice and then mixed with 7 l of the probe mixture, U937 monocytic leukemic cells, but not in control HL-60 cells, a finding consistent with published reports. 41 The which contains 0.2 ng 32 P-labeled E2F probe, 2 l 10× shift buffer (0.2 M HEPES pH 7.9, 0.4 M KC1, 10 mM MgCl 2 , 1 mM majority of complexed E2F in both empty vector and p21
MDA6
antisense cells migrated in the free form with the remainder EGTA, 1 mM EDTA, 1 mM DTT, 1 mM NaF, 1 mM Na 3 VO 4 ), 1 g ssDNA (Sigma), 20 mg BSA (Boehringer Mannheim) and in the position of a p107-cyclin A-E2F complex, as identified in previous gel-retardation assays. 41 Upon stimulation with 0.1% NP-40. After an additional 15 min incubation at room temperature, the reaction products were separated on a 4% PMA, both cell lines displayed a reduction in free E2F. Moreover, the extent of this reduction was at least as great in the polyacrylamide gel in 0.25 × TBE at 300 V for 2.5 h. The gel was dried and detected by autoradiography. p21 MDA6 antisense line as in empty vector controls. In both HL-60/V2 and HL-60/AS5 cells were either untreated or exposed to 5 nM PMA (24 h) or 10 M Ara-C (6 h). Cells were then washed free of drug and 500 residual cells/condition were plated in soft agar. The plates were incubated in a fully humidified atmosphere of 95% air and 5% CO 2 at 37°C and colonies consisting of groups of у50 cells, scored 10-12 days after plating. Colony formation was expressed as the total number of colonies for each condition relative to untreated controls. Values represent the means for four (PMA) or seven (Ara-C) experiments performed in triplicate ± 1 s.d.
up-regulation of p21 MDA6 in HL-60/AS5 cells and dephosphorylation of pRb in both HL-60/AS5 and control cells, we monitored CDK-2 with represents one of the kinases responsible for maintaining pRb in the hyperphosphorylated state. 43, 44 Following treatment of HL-60/AS5 cells with PMA (5 nM; 24 h), CDK-2 activity did not change appreciably. However, activity in PMA-treated HL-60/V2 cells was 31.5 ± 9.3% lower than that observed in their antisense counterparts (P р 0.05; data not shown). This finding is consistent with the attenuated induction of p21 MDA6 in HL-60/AS5 cells.
The ultimate consequence of PMA treatment of HL-60 cells is the induction of cellular maturation. One of the critical events associated with differentiation is cell cycle arrest in G 0 /G 1 , which is thought to be mediated, at least in part, by p21 MDA6 . Therefore, we next examined the cell cycle distribution of antisense expressing and control cells treated with PMA as well as the appearance of the monocytic differentiation marker, CD11b. While both HL-60/AS5 and control cells displayed evidence of G 1 arrest compared to untreated controls, the fraction of HL-60/AS5 cells arrested in G 0 /G 1 was significantly less than that observed in HL-60/V2 cells (Figure 5a) . A similar result was observed in the case of CD11b expression. Both antisense and control cell lines exhibited increases in the percentage of cells expressing CD11b, but this response was significantly attenuated in HL-60/AS5 cells (Figure 5b) . In separate studies, the percentage of apoptotic cells following a 24-h exposure to 5 nM PMA was equivalent in the two cell lines (V2 = 8.7 ± 2.1%; V5 = 7.1 ± 1.6%; P Ͼ 0.05; data not shown). Thus, compared to the HL-60/V2 line, HL-60/AS5 cells were partially impaired in their ability to undergo G 1 arrest and express differentiation markers in response to PMA, but retained their capacity to undergo apoptosis.
Finally, the clonogenic growth of HL-60/V2 and HL-60/AS5 cells was compared following treatment with 5 nM PMA for 24 h (Table 1) . While both cell lines showed a reduction in clonogenic potential, clonogenicity of empty vector cells was significantly lower than that of the antisense cells and empty vector cells indicative of apoptosis (not shown). Subsequently, the extent of apoptosis resulting from Ara-C treatment was examined more rigorously by monitoring low cell lines, the bulk of E2F following PMA treatment migrated in the position of the cyclin A complex. Consequently, the molecular weight DNA fragmentation 45 and morphologic changes in cells exposed to 10 and 100 M Ara-C for 6 h. impairment in p21 MDA6 induction by PMA in antisenseexpressing cells did not abrogate reductions in levels of free Both cell lines exhibited equivalent degrees of DNA fragmentation following treatment with both concentrations of Ara-C E2F. In separate studies, we also examined expression of the CDK inhibitor, p27 kip1 which has been implicated in G 1 arrest (Figure 6b) . Furthermore, when Wright-Giemsa-stained slides of HL-60/V2 and HL-60/AS5 cells treated with 10 M Ara-C of HL-60 cells following exposure to vitamin D 3 and PMA. 37, 42 Modest up-regulation of p27 kip1 expression was observed in were examined for cyto-architectural features of apoptosis, the extent of cell death observed in the two cell lines was equivalboth antisense and empty vector cells following incubation with PMA (Figure 4) . ent (Figures 6c and 7) . These findings were confirmed by TUNEL analysis (not shown). Because of the apparent discordance between attenuated Western blot displaying changes in levels of (a) p21 MDA6 and (b) pRb in response to 10 and 100 M Ara-C for 6 h in HL-60/V2 and HL-60/AS5 cells. Following treatment with 0, 10 and 100 M Ara-C (HL-60/V2, lanes 1, 3, 5; HL-60/AS5, lanes 2, 4, 6, respectively), cells were washed, pelleted and lysed as in Figure 1 . Lane 7 contains lysate from HL-60/V2 cells treated with 5 nM PMA for 24 h and is included as a positive control for p21 MDA6 induction and pRb dephosphorylation. Equivalent amounts of protein (25 g) were separated and transferred to nitrocellulose. Blots were probed with the appropriate primary antibody followed by a goat anti-mouse-peroxidase secondary antibody and developed by chemiluminescence. The position of prestained molecular weight markers is indicated on the left, while the positions of the identified proteins are on the right. Two additional experiments yielded similar results.
Because both HL-60/V2 and HL-60/AS5 cells exhibited Ara-C exposure (Figure 8a ), a finding consistent with the results of an earlier report. 8 Moreover, there was no evidence increases in the percentage of cells in G 0 /G 1 in response to Ara-C, we next examined the status of p21 MDA6 as well as of pRb dephosphorylation (Figure 8b ) an event associated with G 1 arrest and differentiation. 36 Ara-C treatment also did not the downstream effector protein, pRb. Cells were treated with 10 M Ara-C for 6 h and total cell lysates were obtained.
lead to induction of p27 KIP1 in either cell line (data not shown). Collectively, these findings indicate that dysregulDespite the apparent G 1 arrest, p21 MDA6 was not induced by ation of p21 MDA6 in HL-60 cells does not alter the suscepti-60 cells, but the functional significance of this phenomenon was not specifically addressed. 11, 17 Similarly, PMA, okadaic bility of HL-60 cells to Ara-C-induced apoptosis nor does it attenuate Ara-C-mediated G 1 arrest.
acid, and IFN␥ were found to induce p21 MDA6 in three p53-null myeloid leukemia cell lines (HL-60, U937 and K562); Lastly, the clonogenic growth of HL-60/V2 and HL-60/AS5 cells treated with 10 M Ara-C for 6 h was examined. Followmoreover, transfection of K562 cells with p21 MDA6 sense (but not antisense) constructs reduced cloning efficiency. 56 In studing this exposure, both cell lines exhibited an equivalent reduction in cell number relative to controls (ie 12.4 ± 2.2 vs ies involving p53-positive human colon carcinoma cells, Waldman and coworkers 15 reported loss of p21 MDA6 abro-11.5 ± 1.6% respectively; P у 0.05). Furthermore, when residual cells were plated in soft agar, empty vector and gated the G 1 arrest response to doxorubicin. However, to the best of our knowledge, analogous studies in human leukemia antisense-expressing cells exhibited 42.6 and 49.4% reductions in colony formation respectively (P у 0.05; cells lacking p53 have not been conducted. To address this issue, an HL-60 cell line stably expressing a p21 MDA6 antisense Table 1 ). In separate studies, the S-phase fractions of unperturbed HL-60/V2 and HL-60/AS5 were found to be identical construct was generated, and these cells exhibit an unambiguously attenuated induction of p21 MDA6 in response to the (35.9 ± 2.6% vs 35.6 ± 2.9%; P у 0.05). Thus, the failure of p21 MDA6 dysregulation to modify Ara-C-induced apoptosis differentiation-inducing agent PMA. This model system provides a basis for characterizing the functional role that was accompanied by undiminished sensitivity of clonogenic cells to this agent. p21 MDA6 plays in p53-independent pathways of leukemic cell maturation and drug-induced apoptosis.
The , expression of the maturation marker CD11b, the percentage of cells arrested in G 1 , and in the to hypophosphorylation of pRb, which is then free to bind to, and thereby inactivate, the transcription factor, E2F.
46 Inactidegree of inhibition of CDK-2. However, despite the marked attenuation of p21 MDA6 expression, HL-60/AS5 cells exposed vation of E2F prevents transcription of diverse genes involved in cell cycle progression, including c-myc, dihydrofolate to PMA did not appear to be impaired in their capacity to dephosphorylate pRb compared to empty vector controls, nor reductase, thymidine kinase, and ornithine decarboxylase, among others. 34, 36, 47 The arrest of cells in G 1 is believed to be were there obvious perturbations in E2F complex formation. These phenomena may reflect (1) the presence of subtle essential for certain pre-differentiation events to proceed, and for normal maturation to occur. 48 The relationship between changes in pRb and/or E2F status that could not be identified by the present methods and/or (2) the involvement of alternap21 MDA6 and apoptosis is less clear, and conflicting evidence on this point has been presented. For example, expression of tive cell cycle regulatory proteins, such as CDK4 and CDK6, which have also been implicated in pRb phosphorylation.
58 p21 MDA6 appears to be required for some cell types to undergo apoptosis, 16, 23 but not others. 21, 22, 25, 49 In human fibroblasts, In this context, it has been proposed that perturbations in the cyclin A/CDK-2 complex may lead to qualitative alterations expression of p21 MDA6 antisense RNA induced cells in G 0 to progress through the cell cycle but did not trigger apoptosis. 50 in pRb phosphorylation status that could exert effects on cell cycle arrest and related events. 59 Alternatively, p27 kip1 has On the other hand, attenuation of p21 MDA6 in MCF-7 breast cancer cells by antisense constructs has been demonstrated to been implicated in the maturation and G 1 arrest response of HL-60 cells to certain differentiation-inducing stimuli (eg dihypromote prostaglandin A 2 -mediated apoptosis. 23, 51 More recently, antisense oligonucleotides directed against p21 MDA6 droxyvitamin D 3 ). 43 However, the failure to detect clear differences in p27 kip1 induction in empty vector and antisensehave been shown to promote apoptosis in neuroblastoma cells, 52 and enforced expression of p21 MDA6 found to oppose expressing cells argues against the contribution of this CDK inhibitor to the differential response to PMA. cell death in differentiating myocytes. 53 Collectively, the latter studies suggest an anti-apoptotic role for this gene. Indirect
In contrast to results obtained with PMA, dysregulation of p21 MDA6 did not prevent the antimetabolite Ara-C from evidence for this view has been provided by Zhang et al, 54 who reported that high levels of p21 MDA6 expression in leuinducing cell cycle arrest; moreover, HL-60/AS5 cells were fully capable of mounting an apoptotic response to this agent. kemic blasts obtained from patients with AML correlated with a poor response to chemotherapy. Since induction of leuThe latter finding, along with evidence that Ara-C fails to induce p21 MDA6 in the HL-60 cell line, 11 indicates that Arakemic cell maturation (eg by PMA) has been shown to reduce the susceptibility of leukemic cells to drug-induced cell C-mediated apoptosis proceeds along p53-and p21 MDA6 -independent pathways in these cells. The inability of p21 MDA6 dysdeath, 55 it is possible that upregulation of p21 MDA6 represents a component of the differentiation response that antagonizes regulation to influence drug-induced cell cycle block stands in contrast to recent reports demonstrating impairment in apoptosis.
Currently, little direct information is available concerning doxorubicin-induced G 1 arrest in a p21
-deficient colon tumor cell line HCT116. 15 homologous recombination vs antisense expression), or the
